Can Eptifibatide Rewrite the NSTEMI Story? (Eptifibatide vs. Standard Care for NSTEMI: A 5‐Year Analysis of Major Adverse Cardiovascular Events)
Eptifibatide showed no significant effect on MACE or survival in NSTEMI patients undergoing PCI. Further research is needed to explore its role in high-risk subgroups.
Authors
- Parichehr Ghahari (ORCID: https://orcid.org/0009-0005-6434-0148)
- Parvin Kalhor (ORCID: https://orcid.org/0009-0003-4511-7659)
- Mehdi Mehrani (ORCID: https://orcid.org/0000-0001-9831-1074)
- Pargol Nowrouzi
Institutions
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1002/ccd.70242
- Citations
- 1
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39